The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.
Educational reference only. Nothing on this page constitutes medical advice or encourages personal use of this compound. Always consult a qualified healthcare provider before any decision involving your health.
MIC B-12 · lipotropic B12 · methyl donor · Inositol (I): a cyclohexa
Effect demonstrated in multiple animal studies; human data sparse or extrapolated. Grades summarize evidence quality, not whether a compound is appropriate, legal, or risk-free.
No controlled human trial tests the injectable Lipo-B/MIC B-12 combination for weight loss; evidence is component-level nutrition literature and lipotropic-deficiency models, not product-specific RCT evidence.
The default page keeps the decision layer visible first: summary, routes, evidence, and risks. Open the full report for mechanisms, chapter sections, citations, updates, and print/share controls.
Amino-acid-derived quaternary ammonium compound involved in mitochondrial fatty-acid transport. Commercial claims are often overstated, but specific forms have clinical evidence for neuropathy, peripheral artery disease, muscle recovery, male infertility, and post-MI cardiac outcomes.
⚠ NAMING COLLISION: 'Lipo-C' is used for TWO completely different products — this chapter covers the compounded MIC+L-Carnitine+B-vitamins lipotropic injection. Liposomal Vitamin C (a separate oral supplement also called 'Lipo-C') is covered in a separate chapter. Read Section 1 before proceeding. Lipo-B Extended: Adds L-Carnitine, Thiamine (B1), and Dexpanthenol (B5) to the Lipo-B MIC+B12 base. Zero RCTs for the combination. L-Carnitine Injectable Dose is 100-200x Below Oral Therapeutic Doses. Mechanistically Coherent. Clinically Unproven.
MIC injection tradition originates from lipotropic injection protocols developed in bariatric and weight loss medicine